System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Ramadhan T Othman, MBChB, PhD, MSc, FRCP

Oncology — University of Duhok, Iraq

LeadR Profile

Prof Ramadhan T Othman, MBChB, PhD, MSc, FRCP University of Duhok Iraq
99 ScienceLeadR Reputation 99

Unlock

Register Login
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026
Source: PubMed

University of Duhok

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 19

Citations

Citations: 126 1st author: 5 Last author: 5 Unique author: 2

Main journals

Neuro Oncol 4
Asian Pac J Cancer Prev 3
Neurooncol Adv 2
Acta Neuropathol Commun 1
Advanced medical journal 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AIC): a randomized, double-blind, placebo-controlled trial.
biomarkers, anthracyclines		Future Sci OA20260
Overdiagnosis and Overtreatment of Thyroid Cancer, a Single City Experience in the Kurdistan Region/Iraq.
mortality, incidence, neoplasms, thyroid gland, diagnosis, thyroid neoplasms, therapeutics		Asia Pac J Clin Oncol20250
Anthracycline- and HER2-induced cardiotoxicity: mechanisms, current strategies, and the emerging role of dapagliflozin as a targeted cardioprotective agent.
heart, neoplasms, drug therapy, biomarkers, cardiotoxicity, anthracyclines, therapeutics, cardiotonic agents, chemotherapy		Cardiooncology20250
Anticancer activity of cloned Nisin as an alternative therapy for MCF-7 brest cancer cell line.
cells, genes, breast neoplasms, molecular biology, pharmaceutical preparations, neoplasms, nisin, cell biology, cell line, breast, therapeutics		Cell Mol Biol (Noisy-le-grand)20233
Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma.
therapeutics, medulloblastoma		Neurooncol Adv20210

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS